BH WELL has expertise in behavioral health integration and change. We serve as a resource for evidence-based behavioral health practice, programs, and education.
We work in the areas of Wellness, Substance Use Disorder (SUD), Tobacco Policy and Treatment, Long-Acting Injectable Antipsychotics, and Academic Practice Partnership. Click on each category below to learn more.
BH WELL provides resources that may help you navigate your personal path to wellness.
Substance use disorders occur when recurring use of alcohol and/or drugs, including tobacco, cause significant impairment such as health problems, disability, and failure to meet major responsibilities at work, school, or home. It can be hard to deal with addiction on your own that's why we're here to help.
Tobacco use is the leading cause of preventable death in the United States and around the world. Every year more than 8,000 Kentuckians die of illnesses caused by smoking. The good news is that tobacco use, although a chronic addictive behavior, is treatable.
People with severe mental illnesses, such as schizophrenia, face many challenges related to accessing community mental health services and adherence to medication regimen. The advent of Long‐Acting Injectable antipsychotics (LAIs) promises to increase compliance with medication therapy. The purpose of this study is to examine retrospective and prospective data to understand the impact of the use of LAIs among people living with schizophrenia who are Medicaid beneficiaries.
The purpose of the Academic-Practice Partnership is to provide collaboration between the UK College of Nursing, UK HealthCare, and Eastern State Hospital in terms of practice, research, and scholarship. This partnership began in October 2015.
